Literature DB >> 30777371

Effective Technology-based Behaviour Change Interventions in Prostate Cancer Supportive Care: Are We There Yet?

Camille E Short1, Linda Trinh2, Erica L James3.   

Abstract

Entities:  

Year:  2019        PMID： 30777371     DOI： 10.1016/j.eururo.2019.02.001

Source DB:  PubMed          Journal:  Eur Urol        ISSN： 0302-2838            Impact factor:   20.096


× No keyword cloud information.
  4 in total

1.  Evaluating a web- and telephone-based personalised exercise intervention for individuals living with metastatic prostate cancer (ExerciseGuide): protocol for a pilot randomised controlled trial.

Authors:  Holly E L Evans; Cynthia C Forbes; Daniel A Galvão; Corneel Vandelanotte; Robert U Newton; Gary Wittert; Suzanne Chambers; Andrew D Vincent; Ganessan Kichenadasse; Nicholas Brook; Danielle Girard; Camille E Short
Journal:  Pilot Feasibility Stud       Date:  2021-01-11

2.  Evaluating a web-based computer-tailored physical activity intervention for those living with and beyond lung cancer (ExerciseGuide UK): protocol for a single group feasibility and acceptability study.

Authors:  Jordan Curry; Michael Lind; Camille E Short; Corneel Vandelanotte; Holly E L Evans; Mark Pearson; Cynthia C Forbes
Journal:  Pilot Feasibility Stud       Date:  2022-08-13

3.  Examining the Priorities, Needs and Preferences of Men with Metastatic Prostate Cancer in Designing a Personalised eHealth Exercise Intervention.

Authors:  Holly E L Evans; Cynthia C Forbes; Corneel Vandelanotte; Daniel A Galvão; Robert U Newton; Gary Wittert; Suzanne Chambers; Ganessan Kichenadasse; Nicholas Brook; Danielle Girard; Camille E Short
Journal:  Int J Behav Med       Date:  2020-09-23

4.  Optimising Web-Based Computer-Tailored Physical Activity Interventions for Prostate Cancer Survivors: A Randomised Controlled Trial Examining the Impact of Website Architecture on User Engagement.

Authors:  Amy Finlay; Holly Evans; Andrew Vincent; Gary Wittert; Corneel Vandelanotte; Camille E Short
Journal:  Int J Environ Res Public Health       Date:  2020-10-28       Impact factor: 3.390
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.